Google, AHA create a $50M heart drug collaboration

Google Life Sciences ($GOOG) joined the American Heart Association in creating a new $50 million research initiative to find better heart drugs. The groups hope that a multidisciplinary approach to research can do a better job in discovering new cardio therapies, which remains a major challenge as biotechs assess the cost of developing new heart remedies. Story

Suggested Articles

The financing sets AM-Pharma up to advance in sepsis-associated acute kidney injury independently now Pfizer has turned down its option to buy.

The FDA sent Eton's partner, Bausch Health, a complete response letter that raised “no concerns” about the clinical data in the drug’s application.

A new partnership will test drug cocktails containing Karyopharm's new product Xpovio in cell samples from glioblastoma patients.